~~<i id='916E3E91BA'><strike id='916E3E91BA'><tt id='916E3E91BA'><pre id='916E3E91BA'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：explore 2025-10-02 01:23:41 Page View：6848

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Change Healthcare payments predicted restored March 15
Next article： Bright Health sells Medicare Advantage business to Molina

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Create a giant ice tray with this foil pan hack to keep food cold this summer

2:22Afoiltrayfilledwithwatertobefrozen.DanMcCarthyMakesummerentertainingabreezewiththisoversizedicet

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

The U.S. needs a new definition of substance use “recovery”

Adobe“WhenIuseaword,”oneof19thcenturyBritishauthorandmathematicianLewisCarroll’scharactersoncesaid,“